Utilization of Target-Specific, Hypersensitive Strains of Saccharomyces cerevisiae To Determine the Mode of Action of Antifungal Compounds
Authors:
- 1 June 2005
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 49 (6) , 2558-60
Abstract
Target-specific hypersusceptible strains of Saccharomyces cerevisiae were used to screen antifungal compounds. Two novel Erg7p inhibitors were identified, providing proof of principle of the approach taken. However, observed hypersensitivities to antifungals acting via other targets imply that use of this tool to identify the mode of action requires significant deconvolution.Keywords
This publication has 30 references indexed in Scilit:
- Identification and Characterization of Inhibitors of Bacterial Enoyl-Acyl Carrier Protein ReductaseAntimicrobial Agents and Chemotherapy, 2004
- Pyridines and Pyrimidines Mediating Activity against an Efflux-Negative Strain of Candida albicans through Putative Inhibition of Lanosterol DemethylaseAntimicrobial Agents and Chemotherapy, 2004
- An array of target-specific screening strains for antibacterial discoveryNature Biotechnology, 2002
- The identification of myriocin-binding proteinsChemistry & Biology, 1999
- Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter geneMicrobiology, 1997
- Structure-Activity Relationships of C1 and C6 Side Chains of Zaragozic Acid A DerivativesJournal of Medicinal Chemistry, 1994
- Molecular mechanisms of drug resistance in fungiTrends in Microbiology, 1994
- Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progressionCell, 1993
- Terbinafine: Mode of action and properties of the squalene epoxidase inhibitionBritish Journal of Dermatology, 1992
- The gene encoding squalene epoxidase from Saccharomyces cerevisiae: cloning and characterizationGene, 1991